Global Antidiabetic Drug Market Research Professional Survey 2023
This report studies the global Antidiabetic Drug market status and forecast, categorizes the global Antidiabetic Drug market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.
Diabetes mellitus is a kind of chronic comprehensive disease mainly caused by glucose metabolism disorder due to absolute or relative deficiency of insulin or decreased insulin sensitivity of target cells. The occurrence of type 2 diabetes mellitus is a combination of peripheral insulin resistance and β cell dysfunction. the result of. When diabetes patients undergo diet and exercise therapy and diabetes care education, blood glucose control can still not reach the treatment goals, the need for drug treatment-Antidiabetic Drug
The global anti-diabetic drug market is expected to witness significant growth during the forecast period. This growth is attributed due to increasing prevalence of diabetes and rising demand for oral anti-diabetic drugs. In addition, sedentary lifestyle, increasing the percentage of obesity, high-stress levels are considered as a major driving factor for the growth of oral anti-diabetic drugs market. Furthermore, technological advancement and medical reimbursements can also help in fuelling the growth of oral antidiabetic drug market. However, the high cost of drugs is considered as a major restraint for the market. Nonetheless ongoing research and huge market potential can bring growth opportunities for anti-diabetic market within the forecast period.
Based on the class of drug, the global anti-diabetic drug market is segmented into five types: sulfonylureas, meglitinides, biguanides, alpha-glucosidase inhibitors and others. Sulphonylureas segment of oral anti-diabetic drugs market accounted for the largest market share in 2018followed by biguanides derivatives. Sulfonylureas were the largest segment and acquired around 37% of world market share followed by biguanide derivatives in 2018 Sulfonylureas are a class of organic compounds used in medicine and agriculture. They are antidiabetic drugs widely used in the management of type 2 diabetes mellitus. They act by increasing insulin release from the beta cells in the pancreas.
The global Antidiabetic Drug market is valued at 49600 million US$ in 2017 and will reach 96700 million US$ by the end of 2025, growing at a CAGR of 10.0% during 2018-2025.
The major manufacturers covered in this report
Sanofi-Aventis
Eli Lilly
Oramed
Takeda
Boehringer Ingelheim
Novo Nordisk
Halozyme Therapeutics
Bristol-Myers Squibb
Pfizer
Tonghua Dongbao
Biocon
Wockhardt
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
North America
Europe
China
Japan
Southeast Asia
India
We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Alpha-Glucosidase Inhibitors
Biguanides, Sulphonylureas
Glp-1 Agonist
Meglitinides
Dpp-4 Inhibitors
Sglt–2
Thiazolodinediones
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Type I Diabetes
Type II Diabetes
The study objectives of this report are:
To analyze and study the global Antidiabetic Drug sales, value, status (2013-2017) and forecast (2018-2025).
Focuses on the key Antidiabetic Drug manufacturers, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Antidiabetic Drug are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Antidiabetic Drug Manufacturers
Antidiabetic Drug Distributors/Traders/Wholesalers
Antidiabetic Drug Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Antidiabetic Drug market, by end-use.
Detailed analysis and profiles of additional market players.
Global Antidiabetic Drug Market Research Report 2018
1 Antidiabetic Drug Market Overview
1.1 Product Overview and Scope of Antidiabetic Drug
1.2 Antidiabetic Drug Segment by Type (Product Category)
1.2.1 Global Antidiabetic Drug Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Antidiabetic Drug Production Market Share by Type (Product Category) in 2017
1.2.3 Alpha-Glucosidase Inhibitors
1.2.4 Biguanides, Sulphonylureas
1.2.5 Glp-1 Agonist
1.2.6 Meglitinides
1.2.7 Dpp-4 Inhibitors
1.2.8 Sglt–2
1.2.9 Thiazolodinediones
1.3 Global Antidiabetic Drug Segment by Application
1.3.1 Antidiabetic Drug Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Type I Diabetes
1.3.3 Type II Diabetes
1.4 Global Antidiabetic Drug Market by Region (2013-2025)
1.4.1 Global Antidiabetic Drug Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 Southeast Asia Status and Prospect (2013-2025)
1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Antidiabetic Drug (2013-2025)
1.5.1 Global Antidiabetic Drug Revenue Status and Outlook (2013-2025)
1.5.2 Global Antidiabetic Drug Capacity, Production Status and Outlook (2013-2025)
2 Global Antidiabetic Drug Market Competition by Manufacturers
2.1 Global Antidiabetic Drug Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Antidiabetic Drug Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Antidiabetic Drug Production and Share by Manufacturers (2013-2018)
2.2 Global Antidiabetic Drug Revenue and Share by Manufacturers (2013-2018)
2.3 Global Antidiabetic Drug Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Antidiabetic Drug Manufacturing Base Distribution, Sales Area and Product Type
2.5 Antidiabetic Drug Market Competitive Situation and Trends
2.5.1 Antidiabetic Drug Market Concentration Rate
2.5.2 Antidiabetic Drug Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Antidiabetic Drug Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Antidiabetic Drug Capacity and Market Share by Region (2013-2018)
3.2 Global Antidiabetic Drug Production and Market Share by Region (2013-2018)
3.3 Global Antidiabetic Drug Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Antidiabetic Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Antidiabetic Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Antidiabetic Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Antidiabetic Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Antidiabetic Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Antidiabetic Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Antidiabetic Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
4 Global Antidiabetic Drug Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global Antidiabetic Drug Consumption by Region (2013-2018)
4.2 North America Antidiabetic Drug Production, Consumption, Export, Import (2013-2018)
4.3 Europe Antidiabetic Drug Production, Consumption, Export, Import (2013-2018)
4.4 China Antidiabetic Drug Production, Consumption, Export, Import (2013-2018)
4.5 Japan Antidiabetic Drug Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Antidiabetic Drug Production, Consumption, Export, Import (2013-2018)
4.7 India Antidiabetic Drug Production, Consumption, Export, Import (2013-2018)
5 Global Antidiabetic Drug Production, Revenue (Value), Price Trend by Type
5.1 Global Antidiabetic Drug Production and Market Share by Type (2013-2018)
5.2 Global Antidiabetic Drug Revenue and Market Share by Type (2013-2018)
5.3 Global Antidiabetic Drug Price by Type (2013-2018)
5.4 Global Antidiabetic Drug Production Growth by Type (2013-2018)
6 Global Antidiabetic Drug Market Analysis by Application
6.1 Global Antidiabetic Drug Consumption and Market Share by Application (2013-2018)
6.2 Global Antidiabetic Drug Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Antidiabetic Drug Manufacturers Profiles/Analysis
7.1 Sanofi-Aventis
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Antidiabetic Drug Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Sanofi-Aventis Antidiabetic Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 Eli Lilly
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Antidiabetic Drug Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Eli Lilly Antidiabetic Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 Oramed
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Antidiabetic Drug Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Oramed Antidiabetic Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
7.4 Takeda
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Antidiabetic Drug Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Takeda Antidiabetic Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.4.4 Main Business/Business Overview
7.5 Boehringer Ingelheim
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Antidiabetic Drug Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Boehringer Ingelheim Antidiabetic Drug Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
7.5.4 Main Business/Business Overview
7.6 Novo Nordisk
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Antidiabetic Drug Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Novo Nordisk Antidiabetic Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.6.4 Main Business/Business Overview
7.7 Halozyme Therapeutics
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Antidiabetic Drug Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Halozyme Therapeutics Antidiabetic Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.7.4 Main Business/Business Overview
7.8 Bristol-Myers Squibb
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Antidiabetic Drug Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Bristol-Myers Squibb Antidiabetic Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.8.4 Main Business/Business Overview
7.9 Pfizer
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Antidiabetic Drug Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Pfizer Antidiabetic Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.9.4 Main Business/Business Overview
7.10 Tonghua Dongbao
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Antidiabetic Drug Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Tonghua Dongbao Antidiabetic Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2020)
7.10.4 Main Business/Business Overview
7.11 Biocon
7.12 Wockhardt
8 Antidiabetic Drug Manufacturing Cost Analysis
8.1 Antidiabetic Drug Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Antidiabetic Drug
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Antidiabetic Drug Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Antidiabetic Drug Major Manufacturers in 2017
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Antidiabetic Drug Market Forecast (2018-2025)
12.1 Global Antidiabetic Drug Capacity, Production, Revenue Forecast (2018-2025)
12.1.1 Global Antidiabetic Drug Capacity, Production and Growth Rate Forecast (2018-2025)
12.1.2 Global Antidiabetic Drug Revenue and Growth Rate Forecast (2018-2025)
12.1.3 Global Antidiabetic Drug Price and Trend Forecast (2018-2025)
12.2 Global Antidiabetic Drug Production, Consumption , Import and Export Forecast by Region (2018-2025)
12.2.1 North America Antidiabetic Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.2 Europe Antidiabetic Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.3 China Antidiabetic Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.4 Japan Antidiabetic Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.5 Southeast Asia Antidiabetic Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.6 India Antidiabetic Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.3 Global Antidiabetic Drug Production, Revenue and Price Forecast by Type (2018-2025)
12.4 Global Antidiabetic Drug Consumption Forecast by Application (2018-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
List of Tables and Figures
Figure Picture of Antidiabetic Drug
Figure Global Antidiabetic Drug Production () and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Antidiabetic Drug Production Market Share by Types (Product Category) in 2017
Figure Product Picture of Alpha-Glucosidase Inhibitors
Table Major Manufacturers of Alpha-Glucosidase Inhibitors
Figure Product Picture of Biguanides, Sulphonylureas
Table Major Manufacturers of Biguanides, Sulphonylureas
Figure Product Picture of Glp-1 Agonist
Table Major Manufacturers of Glp-1 Agonist
Figure Product Picture of Meglitinides
Table Major Manufacturers of Meglitinides
Figure Product Picture of Dpp-4 Inhibitors
Table Major Manufacturers of Dpp-4 Inhibitors
Figure Product Picture of Sglt–2
Table Major Manufacturers of Sglt–2
Figure Product Picture of Thiazolodinediones
Table Major Manufacturers of Thiazolodinediones
Figure Global Antidiabetic Drug Consumption (K MT) by Applications (2013-2025)
Figure Global Antidiabetic Drug Consumption Market Share by Applications in 2017
Figure Type I Diabetes Examples
Table Key Downstream Customer in Type I Diabetes
Figure Type II Diabetes Examples
Table Key Downstream Customer in Type II Diabetes
Figure Global Antidiabetic Drug Market Size (Million USD), Comparison (K MT) and CAGR (%) by Regions (2013-2025)
Figure North America Antidiabetic Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Antidiabetic Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Antidiabetic Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Antidiabetic Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Antidiabetic Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Antidiabetic Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Antidiabetic Drug Revenue (Million USD) Status and Outlook (2013-2025)
Figure Global Antidiabetic Drug Capacity, Production (K MT) Status and Outlook (2013-2025)
Figure Global Antidiabetic Drug Major Players Product Capacity (K MT) (2013-2018)
Table Global Antidiabetic Drug Capacity (K MT) of Key Manufacturers (2013-2018)
Table Global Antidiabetic Drug Capacity Market Share of Key Manufacturers (2013-2018)
Figure Global Antidiabetic Drug Capacity (K MT) of Key Manufacturers in 2017
Figure Global Antidiabetic Drug Capacity (K MT) of Key Manufacturers in 2018
Figure Global Antidiabetic Drug Major Players Product Production (K MT) (2013-2018)
Table Global Antidiabetic Drug Production (K MT) of Key Manufacturers (2013-2018)
Table Global Antidiabetic Drug Production Share by Manufacturers (2013-2018)
Figure 2017 Antidiabetic Drug Production Share by Manufacturers
Figure 2017 Antidiabetic Drug Production Share by Manufacturers
Figure Global Antidiabetic Drug Major Players Product Revenue (Million USD) (2013-2018)
Table Global Antidiabetic Drug Revenue (Million USD) by Manufacturers (2013-2018)
Table Global Antidiabetic Drug Revenue Share by Manufacturers (2013-2018)
Table 2017 Global Antidiabetic Drug Revenue Share by Manufacturers
Table 2018 Global Antidiabetic Drug Revenue Share by Manufacturers
Table Global Market Antidiabetic Drug Average Price (USD/MT) of Key Manufacturers (2013-2018)
Figure Global Market Antidiabetic Drug Average Price (USD/MT) of Key Manufacturers in 2017
Table Manufacturers Antidiabetic Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Antidiabetic Drug Product Category
Figure Antidiabetic Drug Market Share of Top 3 Manufacturers
Figure Antidiabetic Drug Market Share of Top 5 Manufacturers
Table Global Antidiabetic Drug Capacity (K MT) by Region (2013-2018)
Figure Global Antidiabetic Drug Capacity Market Share by Region (2013-2018)
Figure Global Antidiabetic Drug Capacity Market Share by Region (2013-2018)
Figure 2017 Global Antidiabetic Drug Capacity Market Share by Region
Table Global Antidiabetic Drug Production by Region (2013-2018)
Figure Global Antidiabetic Drug Production (K MT) by Region (2013-2018)
Figure Global Antidiabetic Drug Production Market Share by Region (2013-2018)
Figure 2017 Global Antidiabetic Drug Production Market Share by Region
Table Global Antidiabetic Drug Revenue (Million USD) by Region (2013-2018)
Table Global Antidiabetic Drug Revenue Market Share by Region (2013-2018)
Figure Global Antidiabetic Drug Revenue Market Share by Region (2013-2018)
Table 2017 Global Antidiabetic Drug Revenue Market Share by Region
Figure Global Antidiabetic Drug Capacity, Production (K MT) and Growth Rate (2013-2018)
Table Global Antidiabetic Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Table North America Antidiabetic Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Table Europe Antidiabetic Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Table China Antidiabetic Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Table Japan Antidiabetic Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Table China Antidiabetic Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Table Japan Antidiabetic Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Table Global Antidiabetic Drug Consumption (K MT) Market by Region (2013-2018)
Table Global Antidiabetic Drug Consumption Market Share by Region (2013-2018)
Figure Global Antidiabetic Drug Consumption Market Share by Region (2013-2018)
Figure 2017 Global Antidiabetic Drug Consumption (K MT) Market Share by Region
Table North America Antidiabetic Drug Production, Consumption, Import & Export (K MT) (2013-2018)
Table Europe Antidiabetic Drug Production, Consumption, Import & Export (K MT) (2013-2018)
Table China Antidiabetic Drug Production, Consumption, Import & Export (K MT) (2013-2018)
Table Japan Antidiabetic Drug Production, Consumption, Import & Export (K MT) (2013-2018)
Table Southeast Asia Antidiabetic Drug Production, Consumption, Import & Export (K MT) (2013-2018)
Table India Antidiabetic Drug Production, Consumption, Import & Export (K MT) (2013-2018)
Table Global Antidiabetic Drug Production (K MT) by Type (2013-2018)
Table Global Antidiabetic Drug Production Share by Type (2013-2018)
Figure Production Market Share of Antidiabetic Drug by Type (2013-2018)
Figure 2017 Production Market Share of Antidiabetic Drug by Type
Table Global Antidiabetic Drug Revenue (Million USD) by Type (2013-2018)
Table Global Antidiabetic Drug Revenue Share by Type (2013-2018)
Figure Production Revenue Share of Antidiabetic Drug by Type (2013-2018)
Figure 2017 Revenue Market Share of Antidiabetic Drug by Type
Table Global Antidiabetic Drug Price (USD/MT) by Type (2013-2018)
Figure Global Antidiabetic Drug Production Growth by Type (2013-2018)
Table Global Antidiabetic Drug Consumption (K MT) by Application (2013-2018)
Table Global Antidiabetic Drug Consumption Market Share by Application (2013-2018)
Figure Global Antidiabetic Drug Consumption Market Share by Applications (2013-2018)
Figure Global Antidiabetic Drug Consumption Market Share by Application in 2017
Table Global Antidiabetic Drug Consumption Growth Rate by Application (2013-2018)
Figure Global Antidiabetic Drug Consumption Growth Rate by Application (2013-2018)
Table Sanofi-Aventis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi-Aventis Antidiabetic Drug Capacity, Production (K MT), Revenue (Million USD), Price (Sanofi-Aventis) and Gross Margin (2013-2018)
Figure Sanofi-Aventis Antidiabetic Drug Production Growth Rate (2013-2018)
Figure Sanofi-Aventis Antidiabetic Drug Production Market Share (2013-2018)
Figure Sanofi-Aventis Antidiabetic Drug Revenue Market Share (2013-2018)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Antidiabetic Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Eli Lilly Antidiabetic Drug Production Growth Rate (2013-2018)
Figure Eli Lilly Antidiabetic Drug Production Market Share (2013-2018)
Figure Eli Lilly Antidiabetic Drug Revenue Market Share (2013-2018)
Table Oramed Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Oramed Antidiabetic Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Oramed Antidiabetic Drug Production Growth Rate (2013-2018)
Figure Oramed Antidiabetic Drug Production Market Share (2013-2018)
Figure Oramed Antidiabetic Drug Revenue Market Share (2013-2018)
Table Takeda Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Takeda Antidiabetic Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Takeda Antidiabetic Drug Production Growth Rate (2013-2018)
Figure Takeda Antidiabetic Drug Production Market Share (2013-2018)
Figure Takeda Antidiabetic Drug Revenue Market Share (2013-2018)
Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim Antidiabetic Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Boehringer Ingelheim Antidiabetic Drug Production Growth Rate (2013-2018)
Figure Boehringer Ingelheim Antidiabetic Drug Production Market Share (2013-2018)
Figure Boehringer Ingelheim Antidiabetic Drug Revenue Market Share (2013-2018)
Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novo Nordisk Antidiabetic Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Novo Nordisk Antidiabetic Drug Production Growth Rate (2013-2018)
Figure Novo Nordisk Antidiabetic Drug Production Market Share (2013-2018)
Figure Novo Nordisk Antidiabetic Drug Revenue Market Share (2013-2018)
Table Halozyme Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Halozyme Therapeutics Antidiabetic Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Halozyme Therapeutics Antidiabetic Drug Production Growth Rate (2013-2018)
Figure Halozyme Therapeutics Antidiabetic Drug Production Market Share (2013-2018)
Figure Halozyme Therapeutics Antidiabetic Drug Revenue Market Share (2013-2018)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol-Myers Squibb Antidiabetic Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Bristol-Myers Squibb Antidiabetic Drug Production Growth Rate (2013-2018)
Figure Bristol-Myers Squibb Antidiabetic Drug Production Market Share (2013-2018)
Figure Bristol-Myers Squibb Antidiabetic Drug Revenue Market Share (2013-2018)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Antidiabetic Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Pfizer Antidiabetic Drug Production Growth Rate (2013-2018)
Figure Pfizer Antidiabetic Drug Production Market Share (2013-2018)
Figure Pfizer Antidiabetic Drug Revenue Market Share (2013-2018)
Table Tonghua Dongbao Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Tonghua Dongbao Antidiabetic Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Tonghua Dongbao Antidiabetic Drug Production Growth Rate (2013-2018)
Figure Tonghua Dongbao Antidiabetic Drug Production Market Share (2013-2018)
Figure Tonghua Dongbao Antidiabetic Drug Revenue Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antidiabetic Drug
Figure Manufacturing Process Analysis of Antidiabetic Drug
Figure Antidiabetic Drug Industrial Chain Analysis
Table Raw Materials Sources of Antidiabetic Drug Major Manufacturers in 2017
Table Major Buyers of Antidiabetic Drug
Table Distributors/Traders List
Figure Global Antidiabetic Drug Capacity, Production (K MT) and Growth Rate Forecast (2018-2025)
Figure Global Antidiabetic Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Antidiabetic Drug Price (Million USD) and Trend Forecast (2018-2025)
Table Global Antidiabetic Drug Production (K MT) Forecast by Region (2018-2025)
Figure Global Antidiabetic Drug Production Market Share Forecast by Region (2018-2025)
Table Global Antidiabetic Drug Consumption (K MT) Forecast by Region (2018-2025)
Figure Global Antidiabetic Drug Consumption Market Share Forecast by Region (2018-2025)
Figure North America Antidiabetic Drug Production (K MT) and Growth Rate Forecast (2018-2025)
Figure North America Antidiabetic Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table North America Antidiabetic Drug Production, Consumption, Export and Import (K MT) Forecast (2018-2025)
Figure Europe Antidiabetic Drug Production (K MT) and Growth Rate Forecast (2018-2025)
Figure Europe Antidiabetic Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Europe Antidiabetic Drug Production, Consumption, Export and Import (K MT) Forecast (2018-2025)
Figure China Antidiabetic Drug Production (K MT) and Growth Rate Forecast (2018-2025)
Figure China Antidiabetic Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table China Antidiabetic Drug Production, Consumption, Export and Import (K MT) Forecast (2018-2025)
Figure Japan Antidiabetic Drug Production (K MT) and Growth Rate Forecast (2018-2025)
Figure Japan Antidiabetic Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Japan Antidiabetic Drug Production, Consumption, Export and Import (K MT) Forecast (2018-2025)
Figure Southeast Asia Antidiabetic Drug Production (K MT) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Antidiabetic Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Southeast Asia Antidiabetic Drug Production, Consumption, Export and Import (K MT) Forecast (2018-2025)
Figure India Antidiabetic Drug Production (K MT) and Growth Rate Forecast (2018-2025)
Figure India Antidiabetic Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table India Antidiabetic Drug Production, Consumption, Export and Import (K MT) Forecast (2018-2025)
Table Global Antidiabetic Drug Production (K MT) Forecast by Type (2018-2025)
Figure Global Antidiabetic Drug Production (K MT) Forecast by Type (2018-2025)
Table Global Antidiabetic Drug Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Antidiabetic Drug Revenue Market Share Forecast by Type (2018-2025)
Table Global Antidiabetic Drug Price Forecast by Type (2018-2025)
Table Global Antidiabetic Drug Consumption (K MT) Forecast by Application (2018-2025)
Figure Global Antidiabetic Drug Consumption (K MT) Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source
Research Methodology
The research study released with title "Global Antidiabetic Drug Market Research Professional Survey 2023" involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Key Executives Interviewed
Research Programs/Design
| Historical Data (2017-2022E) |
|
|
| Market Factor Analysis |
|
|
| Market Forecast (2023F-2028F) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate and estimate the global/regional market size by manufacturers, regional splits, product segments and application.
To establish Research coverage of the study with most relevant & functional players HTF MI follows industry standards such as NAICS/SIC/ICB/TRCB, furthermore the sorted list of companies is validated using Product Mapping and business activities and shortlisted by industry perspective.
HTF MI select experienced analyst and associate that are specialized in the domain for conducting research. They prepare a list of companies by region that helps to understand players penetration rate in the market. This companies are further analyses in what segment or application they serve in our market. The list of product and applications are evaluated for each companies dealing in the Global Antidiabetic Drug Market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global. Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Online) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc from Global Antidiabetic Drug Market who then work towards appointment generation.
Primary Data Collection
The primary research is performed by taking the interviews of executives of various companies dealing in the Global Antidiabetic Drug Market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and relevant list of appointee or target primary respondents; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & In Mail, Community Forums, Open Survey, SurveyMonkey etc.
Secondary Sources
The secondary resources considered in the Global Antidiabetic Drug Market study includes company annual reports, press releases, published articles of organizations and associations, and the survey taken through different mediums such as online website and forums, survey monkey, LinkedIn, etc. In addition, the valuable strategic information obtained from industry association, paid database, and investor presentations are also good tool for information to make appropriate iterative validation are used to modify market models and cross-verify primary research and insights.
Market Breakdown and Data Triangulation
To make market engineering data complete; extensive primary research is conducted to gather information and validate the critical numbers derived to be used for calculations of market statistics; market size estimations; forecasting; breakdown; and data triangulation. Both top-down and bottom-up approaches were applied, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Furthermore qualitative and further quantitative analysis is also done for all the numbers arrived at in the market estimation process to list relevant information in the final deliverable report "Global Antidiabetic Drug Market Research Professional Survey 2023" .
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Key Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments |
|
|
| Total Market |
|
|
| Format | Properties | |
|---|---|---|
| 1-User Access | The report is sent in PDF format. The report will be emailed to you. | This is a single user access license, allowing one specific user to access the report. |
| Site User | The study would be provided in PDF format. The report will be emailed to you. | This is a site license, allowing 1-10 employees within your organisation to access the report. |
| Enterprise User | The format of deliverable would be PDF and Excel. | This is an enterprise or corporate license, allowing all employees within your organisation irrespective of geographic location to access the report. |
